Aug 6, 2026 03:15PM
Aug 6, 2026 09:58AM
Aug 6, 2026 07:16AM
Jul 31, 2026 05:13AM
Jul 16, 2026 07:30AM
May 21, 2026 09:17AM
May 21, 2026 09:00AM Piper Sandler on Roivant Sciences (ROIV): 'Mosliciguat Ph2 PHocus Takes Center Stage & Catalyst-Rich 2026'
May 21, 2026 06:37AM
May 21, 2026 06:20AM
May 20, 2026 07:08AM
Mar 30, 2026 09:21AM
Mar 20, 2026 08:38AM
Mar 20, 2026 08:38AM
Mar 4, 2026 08:36AM TD Cowen Reiterates Buy Rating and Top Pick on Roivant Sciences (ROIV)
Mar 4, 2026 06:42AM
Mar 3, 2026 05:30PM
Mar 3, 2026 04:33PM
Mar 3, 2026 04:16PM
Mar 3, 2026 10:51AM
Feb 10, 2026 06:52AM
Feb 10, 2026 06:31AM Roivant Sciences (ROIV) PT Raised to $38 at Goldman Sachs
Feb 10, 2026 06:13AM
Feb 9, 2026 05:57AM
Feb 6, 2026 07:48AM
Jan 6, 2026 07:37AM
Dec 15, 2025 06:40AM
Dec 15, 2025 06:19AM
Dec 12, 2025 06:07AM Guggenheim Reiterates Buy Rating on Roivant Sciences (ROIV) Post Investor Day
Dec 11, 2025 07:32AM
Nov 14, 2025 04:59AM
Nov 11, 2025 04:49AM
Nov 10, 2025 03:58PM
Nov 10, 2025 08:04AM
Oct 30, 2025 02:47PM
Oct 3, 2025 04:35PM Roivant Sciences (ROIV) files mixed shelf
Oct 1, 2025 01:20PM
Oct 1, 2025 01:13PM
Sep 30, 2025 02:17AM
Sep 18, 2025 06:59AM
Sep 17, 2025 04:44PM
Sep 17, 2025 04:10PM
Sep 17, 2025 03:36PM Roivant Sciences (ROIV) PT Raised to $16.50 at BofA Securities
Sep 17, 2025 12:33PM
Sep 10, 2025 01:44PM
Sep 4, 2025 07:02AM
Sep 2, 2025 09:28AM
Aug 12, 2025 06:27AM
Aug 11, 2025 07:08AM
Jul 25, 2025 07:46AM Cantor Fitzgerald Reiterates Overweight Rating on Roivant Sciences (ROIV)
Jul 21, 2025 05:21AM

446,711 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All